Literature DB >> 28785528

A Longitudinal Study of Hardiness as a Buffer for Posttraumatic Stress Symptoms in Mothers of Children with Cancer.

Laura Stoppelbein1,2, Elizabeth McRae1, Leilani Greening3.   

Abstract

Mothers of children diagnosed with cancer have been found to be at a heightened risk for post-traumatic stress symptoms (PTSS). In an effort to identify a potential buffer, hardiness was examined as a protective factor for PTSS among mothers of children that were diagnosed with cancer in the past 2 weeks. Using a prospective design, mothers completed measures of PTSS and hardiness at the time of their child's cancer diagnosis and then again at 6- and 12-months post-diagnosis. Random effects regression analyses revealed that mothers who scored high on hardiness were less likely to experience PTSS after controlling for the effect of time. PTSS cluster-specific relations with hardiness were also examined, which revealed that mothers who scored high on hardiness experienced fewer avoidance/numbing symptoms at the time of their child's diagnosis of cancer and across 12 months; whereas mothers who scored low on hardiness tended to experience more avoidance/numbing symptoms at the time of their child's diagnosis. However, these symptoms declined gradually over the course of 12 months. The present findings support examining hardiness further as a buffer against specific PTSS clusters and exploring options for identifying and treating mothers of children with cancer that may be at risk for PTSS.

Entities:  

Year:  2017        PMID: 28785528      PMCID: PMC5544057          DOI: 10.1037/cpp0000168

Source DB:  PubMed          Journal:  Clin Pract Pediatr Psychol        ISSN: 2169-4826


  39 in total

1.  Social support and resilience to stress: from neurobiology to clinical practice.

Authors:  Fatih Ozbay; Douglas C Johnson; Eleni Dimoulas; C A Morgan; Dennis Charney; Steven Southwick
Journal:  Psychiatry (Edgmont)       Date:  2007-05

2.  The role of cortisol in PTSD among women exposed to a trauma-related stressor.

Authors:  L Stoppelbein; L Greening; Paula Fite
Journal:  J Anxiety Disord       Date:  2011-12-13

Review 3.  Outcomes of posttraumatic stress disorder.

Authors:  N Breslau
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

4.  Resilience-recovery factors in post-traumatic stress disorder among female and male Vietnam veterans: hardiness, postwar social support, and additional stressful life events.

Authors:  L A King; D W King; J A Fairbank; T M Keane; G A Adams
Journal:  J Pers Soc Psychol       Date:  1998-02

5.  Hardiness: an examination of its relationship with positive and negative long term changes following trauma.

Authors:  M Waysman; J Schwarzwald; Z Solomon
Journal:  J Trauma Stress       Date:  2001-07

Review 6.  Gender differences in posttraumatic stress disorder.

Authors:  Miranda Olff; Willie Langeland; Nel Draijer; Berthold P R Gersons
Journal:  Psychol Bull       Date:  2007-03       Impact factor: 17.737

7.  A randomized controlled trial of a self-guided, multimedia, stress management and resilience training program.

Authors:  Raphael D Rose; Jay C Buckey; Tomislav D Zbozinek; Sarosh J Motivala; Daniel E Glenn; James A Cartreine; Michelle G Craske
Journal:  Behav Res Ther       Date:  2012-11-21

8.  Gender differences in the sensitivity to posttraumatic stress disorder: An epidemiological study of urban young adults.

Authors:  Naomi Breslau; James C Anthony
Journal:  J Abnorm Psychol       Date:  2007-08

9.  A longitudinal study of the role of cortisol in posttraumatic stress disorder symptom clusters.

Authors:  Laura Stoppelbein; Leilani Greening
Journal:  Anxiety Stress Coping       Date:  2014-06-17

10.  Psychological resilience and postdeployment social support protect against traumatic stress and depressive symptoms in soldiers returning from Operations Enduring Freedom and Iraqi Freedom.

Authors:  Robert H Pietrzak; Douglas C Johnson; Marc B Goldstein; James C Malley; Steven M Southwick
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.